RXR β 2 Antibodies

Santa Cruz Biotechnology delivers a wide array of RXR β 2 monoclonal antibodies for research focused on understanding nuclear receptor signaling pathways. RXR β 2 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). RXR β 2, or Retinoid X Receptor beta 2, is a member of the nuclear receptor superfamily and plays a vital role in mediating the effects of retinoids and thyroid hormones on gene expression. RXR β 2 participates in numerous biological processes, including cell differentiation, metabolism, and the regulation of immune responses. Understanding RXR β 2 function is essential for elucidating its implications in various diseases, including cancer and metabolic disorders. Researchers can utilize RXR β 2 monoclonal antibodies to explore molecular mechanisms and signaling pathways in different experimental models. Advanced detection methods using conjugated secondary antibodies, such as horseradish peroxidase (HRP), phycoerythrin (PE), and fluorescein isothiocyanate (FITC), enable precise visualization of RXR β 2 expression patterns. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific understanding of nuclear receptor biology and disease mechanisms.